LL-BM 726

• CAT Number: I030899
• CAS Number: 96695-56-6
• Molecular Formula: C13H21N5O5
• Molecular Weight: 327.34
• Purity: 98%
• Synonyms: LL-BM 726; LL BM 726; LLBM 726; LL-BM-726; LLBM726; LL BM 726
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 2-[[2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-2-(1-hydroxy-2-oxocyclopent-3-en-1-yl)acetic acid
• InChI: InChI=1S/C13H21N5O5/c14-7(3-2-6-17-12(15)16)10(20)18-9(11(21)22)13(23)5-1-4-8(13)19/h1,4,7,9,23H,2-3,5-6,14H2,(H,18,20)(H,21,22)(H4,15,16,17)
• InChIKey: DUYFQYOHZRZEAZ-UHFFFAOYSA-N
• SMILES: C1C=CC(=O)C1(C(C(=O)O)NC(=O)C(CCCN=C(N)N)N)O

LL-BM 726（Cat No.:I030899）is an experimental compound being studied for its potential as a selective inhibitor of certain enzymes involved in cellular signaling pathways. It is primarily being investigated for its therapeutic applications in cancer, where it may help inhibit tumor growth by interfering with key cellular processes such as proliferation, survival, and metastasis. Preclinical studies have shown that LL-BM 726 can target specific molecular targets, potentially overcoming drug resistance seen in certain cancer types. However, its full mechanism of action, safety, and efficacy are still being explored through ongoing research and clinical trials.

Reference

1: Ellestad GA, James JC, Morton GO, Siegel MM, McGahren WJ. LL-BM726: a novel dipeptide antibiotic. J Antibiot (Tokyo). 1985 Apr;38(4):541-3. PubMed PMID: 3839233.